UDK: 616.921.5 (08)
E. A. Ioannidi, S. F. Popov, O. V. Alexandrov
Кафедра инфекционных болезней с эпидемиологией и тропической медициной ВолгГМУ
Clinical experience of administration of «Neosmectin» sorbent in treatment of patients with seasonal and pandemic influenza is described in the article. As has been found, the use of «Neosmectin» enterosorbent in combination with traditional etiotropic and pathogenetic therapy effectively reduces the duration of the intoxication syndrome and relieves dyspeptic disorders in patients with influenza.
influenza A (H1N1, California, 2009), enterosorbents, neosmectin, inductors of synthesis of endogenic interferon, inhibitors of virus neuraminidase